XTL Biopharmaceuticals Ltd. (XTLB)

XTL Biopharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.82	1.4	2.09	2.97	3.63	4.46
Short-Term Investments	0.9	-	-	-	-	2.27
Trading Asset Securities	-	0.61	1.63	3.16	2.41	-
Cash & Short-Term Investments	1.72	2.01	3.72	6.13	6.04	6.73
Cash Growth	-22.03%	-46.09%	-39.27%	1.41%	-10.20%	-17.16%
Accounts Receivable	0.14	-	-	-	-	-
Receivables	0.14	-	-	-	-	-
Prepaid Expenses	0.13	0.03	0.07	0.09	0.07	0.08
Other Current Assets	-	0.01	0.01	0.02	0.01	0.02
Total Current Assets	1.99	2.05	3.81	6.24	6.12	6.83
Property, Plant & Equipment	0.22	-	-	0	0	0
Other Intangible Assets	7.08	0.38	0.38	0.38	0.38	0.38
Total Assets	9.28	2.43	4.19	6.62	6.5	7.21
Accounts Payable	0.55	0	0	0	0	0
Accrued Expenses	-	0.21	0.19	0.23	0.25	0.23
Other Current Liabilities	1.91	-	-	-	-	-
Total Current Liabilities	2.47	0.21	0.19	0.23	0.25	0.23
Other Long-Term Liabilities	1.1	-	-	1.05	2.64	0.47
Total Liabilities	3.56	0.21	0.19	1.29	2.89	0.7
Common Stock	23.14	14.12	14.12	14.12	13.18	13.18
Additional Paid-In Capital	141.33	146.33	146.33	146.33	146.02	146.02
Retained Earnings	-158.77	-158.25	-156.47	-155.13	-155.61	-152.7
Comprehensive Income & Other	0.02	0.02	0.02	0.02	0.02	0.02
Total Common Equity	5.72	2.22	4	5.33	3.61	6.52
Shareholders' Equity	5.72	2.22	4	5.33	3.61	6.52
Total Liabilities & Equity	9.28	2.43	4.19	6.62	6.5	7.21
Net Cash (Debt)	1.72	2.01	3.72	6.13	6.04	6.73
Net Cash Growth	-22.03%	-46.09%	-39.27%	1.41%	-10.20%	-17.16%
Net Cash Per Share	0.00	0.00	0.01	0.01	0.01	0.01
Filing Date Shares Outstanding	881.39	544.91	544.91	544.91	514.21	514.21
Total Common Shares Outstanding	881.39	544.91	544.91	544.91	514.21	514.21
Working Capital	-0.48	1.84	3.62	6.01	5.87	6.6
Book Value Per Share	0.01	0.00	0.01	0.01	0.01	0.01
Tangible Book Value	-1.36	1.84	3.62	4.95	3.23	6.14
Tangible Book Value Per Share	-0.00	0.00	0.01	0.01	0.01	0.01

Updated Dec 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q